Resilient Pharma Supply Chain

Now is the time to design pharmaceutical supply chains to manage the risks of today and succeed in the future.
Drug shortages have reached record-breaking levels over the past 18 months as pharmaceutical supply chains suffer from the pressures and demands of the pandemic. The shortages have impacted pharmaceutical companies, hospitals and healthcare systems, and most importantly, patients. However, even when the pandemic has subsided, pharmaceutical supply chains will likely continue to face challenges.

COVID-19 demonstrated how vulnerable pharmaceutical supply chains are to major demand shifts and supply shocks caused by geopolitical tensions, local regulations, and sole-source suppliers. In the midst of these challenges, the typical safety nets of pharmaceutical companies-conservatively designed networks and well-resourced safety stocks-have proven ineffective.

Looking ahead, pharmaceutical companies must redesign their supply chains. By implementing innovative risk management strategies, companies can proactively respond to modern challenges and create resilient supply chains that are ready for the future.